According to AnaptysBio's latest financial reports the company's current EPS (TTM) is -HK$40.35. In 2022 the company made an earnings per share (EPS) of -HK$35.53 a decrease over its 2021 EPS that were of -HK$16.33.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$40.69 | 14.53% |
2022 | -HK$35.53 | 117.62% |
2021 | -HK$16.33 | 187.67% |
2020 | -HK$5.68 | -79.78% |
2019 | -HK$28.06 | 44.4% |
2018 | -HK$19.44 | 53.37% |
2017 | -HK$12.67 | 348.71% |
2016 | -HK$2.82 | 2.11% |
2015 | -HK$2.77 |